Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health · Department of Health and Human Services
At a glance
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) is an open federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). Applications are due November 6, 2026. Individual awards are listed as up to $350K, with $350K in total estimated funding. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.121 (Oral Diseases and Disorders Research) and 3 other listings.
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Posted
- Nov 18, 2024
- Close date
- Nov 6, 2026
- Archive date
- Dec 6, 2026
- Award floor
- Not specified
- Award ceiling
- $350,000
- Est. total funding
- $350,000
- Expected awards
- Not specified
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.
Assistance Listings
What is an ALN?- 93.121Oral Diseases and Disorders ResearchProgram →
- 93.172Human Genome ResearchProgram →
- 93.393Cancer Cause and Prevention ResearchProgram →
- 93.866Aging ResearchProgram →
Reported obligations under ALN 93.121
Historical data · not a predictionAgency contact (as published)
National Institutes of Health
grantsinfo@nih.gov
301-402-2541
Quick answers
When is the deadline for this opportunity?
According to the official notice, applications are due November 6, 2026. Confirm the deadline and submission time on Grants.gov before applying.
Who is eligible to apply for this opportunity?
The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How much funding is available through this opportunity?
Per the notice, individual awards are listed as up to $350k and total estimated program funding is $350,000.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity PAR-25-095), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health- Award range
- Up to $200K
- Closes
- Nov 17, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Jul 12, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Jul 17, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Sep 7, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Up to $375K
- Closes
- Jan 7, 2028
- Who can apply
- Public colleges & universities, Private colleges & universities and Others (see notice)
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Up to $375K
- Closes
- Jan 7, 2028
- Who can apply
- Public colleges & universities, Private colleges & universities and Others (see notice)